IP Library › Granted Patent US 11,028,366
Granted Patent B2
US 11,028,366 · App. 16/362,037 · Granted Jun 8, 2021

Methods of differentiating stem cells by modulating MIR-124

Inventors: Jau-Nan Lee (Kaohsiung, TW); Tony Tung-Yin Lee (Yakima, WA); Yuta Lee (Kaohsiung, TW)
Assignee: Accelerated BioSciences Corp.
C12N5/0678A61K35/39C12N5/0605C12P19/34C12P21/02G01N33/507G01N33/5023G01N33/5073C12N2501/115C12N2501/65C12N2506/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,028,366
App. No.
16/362,037
Granted
Jun 8, 2021
Kind
B2
Abstract

Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.

Claims (8)

1. A method for increasing insulin production in a human in need thereof, comprising administering an isolated human pancreatic progenitor cell to the human in need thereof, wherein the isolated human pancreatic progenitor cell expresses insulin and betatrophin, whereby the insulin production in the human is increased in response to glucose stimulation in the human.

2. The method of claim 1 , wherein the isolated pancreatic progenitor cell further expresses C-peptide.

3. The method of claim 1 , wherein the isolated pancreatic progenitor cell further expresses Ngn3.

4. The method of claim 1 , wherein the isolated pancreatic progenitor cell further expresses C-peptide and Ngn3.

5. The method of claim 1 , wherein the human in need thereof has one or more symptoms associated with diabetes.

6. The method of claim 5 , wherein the one or more symptoms is polyuria, polydipsia, polyphagia, weight loss, blurred vision, itchiness, peripheral neuropathy, recurrent vaginal infection, fatigue, slow healing of wounds, slow healing of sores, or any combination thereof.

7. The method of claim 1 , wherein the administering comprises injecting the isolated pancreatic progenitor cell to the human in need thereof.

8. The method of claim 1 , wherein the administering comprises implanting the isolated pancreatic progenitor cell to the human in need thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2019
From: LEE, JAU-NAN; LEE, TONY TUNG-YIN; LEE, YUTA
To: ACCELERATED BIOSCIENCES CORP.
Reel/Frame 049749/0019 →
Continuity (5)
Division 15240190 · Aug 18, 2016
Division 14090804 · Nov 26, 2013
Provisional Application 61732162 · Nov 30, 2012
Provisional Application 61877156 · Sep 12, 2013
Related Publication 20190211311A1 · Jul 11, 2019